Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

A deletion causing NF2 exon 9 skipping is associated with familial autosomal dominant intramedullary ependymoma.

Zemmoura I, Vourc'h P, Paubel A, Parfait B, Cohen J, Bilan F, Kitzis A, Rousselot C, Parker F, François P, Andres CR.

Neuro Oncol. 2014 Jan;16(2):250-5. doi: 10.1093/neuonc/not165. Epub 2013 Dec 18.

2.

Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas.

Birch BD, Johnson JP, Parsa A, Desai RD, Yoon JT, Lycette CA, Li YM, Bruce JN.

Neurosurgery. 1996 Jul;39(1):135-40.

PMID:
8805149
3.

Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.

Singh PK, Gutmann DH, Fuller CE, Newsham IF, Perry A.

Mod Pathol. 2002 May;15(5):526-31.

4.

Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.

Lamszus K, Lachenmayer L, Heinemann U, Kluwe L, Finckh U, Höppner W, Stavrou D, Fillbrandt R, Westphal M.

Int J Cancer. 2001 Mar 15;91(6):803-8.

5.

Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.

von Haken MS, White EC, Daneshvar-Shyesther L, Sih S, Choi E, Kalra R, Cogen PH.

Genes Chromosomes Cancer. 1996 Sep;17(1):37-44.

PMID:
8889505
6.

Analysis of the NF2 gene in oligodendrogliomas and ependymomas.

Alonso ME, Bello MJ, Arjona D, Gonzalez-Gomez P, Lomas J, de Campos JM, Kusak ME, Isla A, Rey JA.

Cancer Genet Cytogenet. 2002 Apr 1;134(1):1-5.

PMID:
11996787
7.

Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.

Ebert C, von Haken M, Meyer-Puttlitz B, Wiestler OD, Reifenberger G, Pietsch T, von Deimling A.

Am J Pathol. 1999 Aug;155(2):627-32.

8.

Cerebral and spinal cord tanycytic ependymomas in a young adult with a mutation in the NF2 gene.

Kuga Y, Ohnishi H, Kodama Y, Takakura S, Hayashi M, Yagi R, Fukutome K, Matsushima K, Okamoto K, Taomoto K, Takahashi H.

Neuropathology. 2014 Aug;34(4):406-13. doi: 10.1111/neup.12109. Epub 2014 Mar 10.

PMID:
24612193
9.

Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.

Rubio MP, Correa KM, Ramesh V, MacCollin MM, Jacoby LB, von Deimling A, Gusella JF, Louis DN.

Cancer Res. 1994 Jan 1;54(1):45-7.

10.

Alterations of protein 4.1 family members in ependymomas: a study of 84 cases.

Rajaram V, Gutmann DH, Prasad SK, Mansur DB, Perry A.

Mod Pathol. 2005 Jul;18(7):991-7.

11.

Novel neurofibromatosis type 2 mutation presenting with status epilepticus.

DiFrancesco JC, Sestini R, Cossu F, Bolognesi M, Sala E, Mariani S, Saracchi E, Papi L, Ferrarese C.

Epileptic Disord. 2014 Mar;16(1):132-7. doi: 10.1684/epd.2014.0647.

12.

Multiple primary intramedullary ependymomas: a case report and review of the literature.

Bydon M, Mathios D, Aguayo-Alvarez JJ, Ho C, Gokaslan ZL, Bydon A.

Spine J. 2013 Oct;13(10):1379-86. doi: 10.1016/j.spinee.2013.06.037. Epub 2013 Aug 27. Review.

PMID:
23988460
13.

Neurofibromatosis type 2: molecular and clinical analyses in Argentine sporadic and familial cases.

Ferrer M, Schulze A, Gonzalez S, Ferreiro V, Ciavarelli P, Otero J, Giliberto F, Basso A, Szijan I.

Neurosci Lett. 2010 Aug 9;480(1):49-54. doi: 10.1016/j.neulet.2010.05.094. Epub 2010 Jun 8.

PMID:
20553997
14.

Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.

Koga H, Araki N, Takeshima H, Nishi T, Hirota T, Kimura Y, Nakao M, Saya H.

Oncogene. 1998 Aug 20;17(7):801-10.

15.

Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas.

Slavc I, MacCollin MM, Dunn M, Jones S, Sutton L, Gusella JF, Biegel JA.

Int J Cancer. 1995 Aug 22;64(4):243-7.

PMID:
7657387
16.

Merlin expression in pediatric anaplastic ependymomas real time PCR study.

Buccoliero AM, Castiglione F, Rossi Degl'Innocenti D, Sardi I, Genitori L, Taddei GL.

Fetal Pediatr Pathol. 2010;29(4):245-54. doi: 10.3109/15513811003789644.

PMID:
20594149
17.

Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases.

Maxwell M, Shih SD, Galanopoulos T, Hedley-Whyte ET, Cosgrove GR.

J Neurosurg. 1998 Mar;88(3):562-9.

PMID:
9488313
18.

NF2 tumor suppressor gene: a comprehensive and efficient detection of somatic mutations by denaturing HPLC and microarray-CGH.

Szijan I, Rochefort D, Bruder C, Surace E, Machiavelli G, Dalamon V, Cotignola J, Ferreiro V, Campero A, Basso A, Dumanski JP, Rouleau GA.

Neuromolecular Med. 2003;3(1):41-52.

PMID:
12665675
19.

The response of spinal cord ependymomas to bevacizumab in patients with neurofibromatosis Type 2.

Morris KA, Afridi SK, Evans DG, Hensiek AE, McCabe MG, Kellett M, Halliday D, Pretorius PM, Parry A; , on behalf of the UK NF2 Research Group.

J Neurosurg Spine. 2017 Apr;26(4):474-482. doi: 10.3171/2016.8.SPINE16589. Epub 2016 Dec 16.

PMID:
27982762
20.

Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype.

Patronas NJ, Courcoutsakis N, Bromley CM, Katzman GL, MacCollin M, Parry DM.

Radiology. 2001 Feb;218(2):434-42.

PMID:
11161159

Supplemental Content

Support Center